Mrs Cynthia Lee Probasco, RN | |
636 Maynard Blvd, Jacksonville, NC 28546-9106 | |
(910) 347-7596 | |
(910) 347-7596 |
Full Name | Mrs Cynthia Lee Probasco |
---|---|
Gender | Female |
Speciality | Registered Nurse - Medical-surgical |
Location | 636 Maynard Blvd, Jacksonville, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033389457 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WM0705X | Registered Nurse - Medical-surgical | 195141 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Cynthia Lee Probasco, RN 636 Maynard Boulevard, Jacksonville, NC 28546 Ph: (910) 347-7596 | Mrs Cynthia Lee Probasco, RN 636 Maynard Blvd, Jacksonville, NC 28546-9106 Ph: (910) 347-7596 |
News Archive
ATP - adenosine triphosphate, the vital energy source that keeps our body's cells alive, runs amok at the site of a spinal cord injury, pouring into the area around the wound and killing the cells that normally allow us to move, scientists report in the cover story of the August issue of Nature Medicine.
While national immunization rates remain high, vaccine refusals are troubling. In some parts of the country, pockets of unimmunized children have left communities vulnerable to vaccine-preventable diseases, leading to outbreaks.
Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease.
Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.
Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd, announce the first publication describing a potential new anti-angiogenic therapy based on a natural protein first discovered at QUB. Anti-angiogenics prevent the growth of new blood vessels in tumours and starve them of nutrients, leading to inhibition of tumour growth.
› Verified 5 days ago
Mrs. Judith Ann Damstrom, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 414 Creedmoor Rd, Jacksonville, NC 28546 Phone: 910-581-0116 | |
Melissa Kline, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 317 Western Blvd, Icu, Jacksonville, NC 28546 Phone: 910-577-2351 | |
Marjorie Ann Feely, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 891 Lynchburg Dr, Jacksonville, NC 28546 Phone: 910-346-8123 | |
Christie Bucao, MSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1013 Commons Drive North, Jacksonville, NC 28546 Phone: 571-242-3407 | |
Sheila Anne Maaran, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 123 Henderson Dr, Jacksonville, NC 28540 Phone: 910-353-5555 Fax: 910-353-4833 | |
Mrs. Jenna Leigh Onofrio, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4006 Henderson Dr, Jacksonville, NC 28546 Phone: 910-353-6406 Fax: 910-482-5112 |